Keyphrases
Transient Receptor Potential Vanilloid 1 (TRPV1)
100%
Drug Target
100%
Scleroderma
100%
Activated Macrophages
100%
Bleomycin
100%
Gene-deficient Mice
100%
Dermal Fibrosis
100%
Macrophages
40%
M2 Macrophages
30%
Systemic Sclerosis
20%
Wild Mice
20%
Interleukin-4 (IL-4)
20%
Fibrotic Response
10%
YKL-40
10%
Arginase-1 (Arg-1)
10%
Rheumatologic Diseases
10%
Neurogenic Inflammation
10%
Inflammation Resolution
10%
Alternatively Activated
10%
Skin Manifestations
10%
Non-selective Cation Channel
10%
Macrophage Markers
10%
Inflammatory Response
10%
Collagen 1A1
10%
MRC1
10%
Systemic Scleroderma
10%
Collagen Accumulation
10%
Pro-fibrotic Factors
10%
Fibronectin 1
10%
Channel Activation
10%
Transforming Growth Factor-β
10%
Marker Expression
10%
Skin Fibrosis
10%
Possible Mechanisms
10%
Fibrosis
10%
Wound Healing
10%
Immunology and Microbiology
Experimental Model
100%
Scleroderma
100%
Macrophage Activation
100%
Macrophage
71%
Systemic Scleroderma
42%
Wild Type Mouse
28%
M2 Macrophages
28%
Wild Type
28%
Interleukin 4
28%
Non-Selective Cation Channel
14%
Connective Tissue Growth Factor
14%
Wound Healing
14%
Neurogenic Inflammation
14%
Rheumatic Disease
14%
Inflammation Response
14%
Transforming Growth Factor Beta
14%
Fibronectin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Fibrosis
100%
Scleroderma
100%
Bleomycin
100%
Systemic Sclerosis
42%
Diseases
42%
Inflammation
28%
Wild Type Mouse
28%
Interleukin 4
28%
Peroxisome Proliferator Activated Receptor
14%
Rheumatic Disease
14%
Transforming Growth Factor Beta
14%
Wound Healing
14%
Connective Tissue Growth Factor
14%
Fibronectin
14%
Cation Channel
14%
Skin Manifestation
14%
Neurogenic Inflammation
14%